A Phase 1B Study of the Safety and Tolerability of INB039110 in Combination with Gemcitabine and nab-Paclitaxel in Subjects with Advanced Solid Tumors
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to find out if the drug INCB039110 is safe and tolerable in combination with a chemotherapy medicine called gemcitabine and another chemotherapy medicine called nab-paclitaxel.
Description
The purpose of this study is to test the hypothesis that INCB039110 can be administered safely in combination with gemcitabine and nab-paclitaxel in subjects with advanced or metastatic cancer.
Details
| Condition | Advanced Solid Tumor |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX3502 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.